The race to find effective treatments for COVID-19 isn’t just about developing new drugs. University of Florida Health scientists are studying a trio of existing medications known to have broad antiviral activity.
The incoming class features 21 Ph.D. and two residential master’s students, from nine states and four countries.
Researchers at the University of Florida have received a $3.5 million grant from the National Heart, Lung and Blood Institute, or NHLBI, to study the effect of using genetic information to guide therapy after an angioplasty heart procedure to prevent heart attacks and strokes.
Graduate students Ariana Brice-Tutt and Mohammed Gbadamosi received AFPE Pre-Doctoral Research Fellowships, while Razanne Oueini, a Pharm.D. student, received a Gateway to Research Fellowship award.
Odedina will serve a three-year term on the Minorities in Cancer Research Council of the American Association for Cancer Research.
The faculty were recognized for their contributions to the University of Florida, their profession and society.
The University of Florida College of Pharmacy received a record $28.3 million in research awards in 2019.
The top two scoring abstracts for the 2020 American Society of Clinical Pharmacology and Therapeutics’ Presidential Trainee Awards belong to Marwa Tantawy and Karthik Lingineni.
Lamba is one of 33 faculty members across the university to be named a 2020 UF Research Foundation Professor.
The drug hydroxychloroquine is dominating the news as a possible weapon in the fight against COVID-19. A UF College of Pharmacy infectious diseases expert separates facts from fiction.
